6965:TSEHamamatsu Photonics K.K. Analysis
Data as of 2026-05-21 - not real-time
NT$75.40
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Chung Jye Investment is trading at TWD 75.4, well below its 20‑day SMA of 82.8 and 200‑day SMA of 88.8, signaling a bearish trend despite an oversold RSI of 20.5. Technical indicators such as a bearish MACD (‑2.77 line vs ‑1.72 signal) and a negative histogram reinforce downside pressure, though volume is increasing and the price sits just above the nearest support at 74.6. Fundamentally, revenue has slumped 21.7% year‑over‑year and operating margins remain negative (‑1.7%), while profit margins are a thin 1.2% and ROE is under 2%, suggesting weak earnings quality. The company’s dividend yield appears attractive at 7.88%, but the payout ratio of 171% is clearly unsustainable, raising the risk of a future cut. Valuation metrics are mixed: a forward PE of 7.65 and price‑to‑book of 0.98 hint at relative cheapness, yet the DCF‑derived fair value of 48.2 is far below the current price, indicating the stock is overvalued on a cash‑flow basis. High 30‑day volatility (21.5%) and a historic max drawdown of ‑34.9% add to the risk profile, while a low beta of 0.17 suggests limited market‑wide correlation. The “Extreme Greed” sentiment index (90.3) reflects aggressive market optimism that may be unjustified given the company’s deteriorating fundamentals. Overall, the combination of technical weakness, earnings decline, and an unsustainable dividend makes the near‑term outlook cautious, though the low valuation multiples could attract value‑oriented investors if earnings improve.
Given these dynamics, investors should weigh the potential for a short‑term bounce against the longer‑term risk of earnings deterioration and dividend reduction, keeping an eye on any earnings guidance or dividend policy changes that could shift the risk/reward balance.
Given these dynamics, investors should weigh the potential for a short‑term bounce against the longer‑term risk of earnings deterioration and dividend reduction, keeping an eye on any earnings guidance or dividend policy changes that could shift the risk/reward balance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI in oversold territory suggests possible rebound
- Bearish MACD and price below key moving averages
- Proximity to support level at 74.6
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Forward PE of 7.65 indicates earnings upside
- Low beta (0.17) reduces market‑wide volatility exposure
- Price‑to‑book below 1 points to potential value entry
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- DCF fair value of 48.2 far below current price
- Unsustainable dividend payout ratio (>170%)
- Continued revenue decline and negative operating margins
Key Metrics & Analysis
Financial Health
Revenue Growth-21.70%
Profit Margin1.24%
P/E Ratio21.5
ROE1.99%
ROA0.60%
Debt/Equity0.41
P/B Ratio1.0
Op. Cash FlowNT$1.2B
Free Cash FlowNT$271.9M
Technical Analysis
TrendBearish
RSI20.5
SupportNT$74.60
ResistanceNT$87.60
MA 20NT$82.76
MA 50NT$84.58
MA 200NT$88.78
MACDBearish
VolumeIncreasing
Fear & Greed Index90.29
Valuation
Fair ValueNT$48.18
Target PriceNT$86.40
Upside/Downside14.59%
GradeOvervalued
TypeValue
Dividend Yield7.88%
Risk Assessment
Beta0.17
Volatility21.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.